A serological study of 4,631 participants from all municipalities in Timor-Leste has confirmed the near absence of malaria transmission. The seroprevalence of recent exposure to Plasmodium falciparum antigens was 1.4% and to Plasmodium vivax 0.2%, data consistent with the absence of ongoing transmission. The analysis supports surveillance data and the WHO certification of Timor-Leste as malaria-free, with zero autochthonous cases reported since 2022.


